Published in Cochrane Database Syst Rev on October 08, 2008
Management of trypanosomiasis and leishmaniasis. Br Med Bull (2012) 1.78
Photodynamic therapy for localized infections--state of the art. Photodiagnosis Photodyn Ther (2009) 1.73
Photodynamic therapy for infections: clinical applications. Lasers Surg Med (2011) 1.42
Leishmaniasis: clinical syndromes and treatment. QJM (2013) 1.27
Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in Panama. Am J Trop Med Hyg (2013) 1.07
Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis. PLoS Negl Trop Dis (2013) 1.03
Intracellular targeting specificity of novel phthalocyanines assessed in a host-parasite model for developing potential photodynamic medicine. PLoS One (2011) 0.98
Current evidence and applications of photodynamic therapy in dermatology. Clin Cosmet Investig Dermatol (2014) 0.96
A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection. PLoS Negl Trop Dis (2010) 0.95
Leishmaniasis in the United States: treatment in 2012. Am J Trop Med Hyg (2012) 0.94
Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide. PLoS Negl Trop Dis (2014) 0.88
Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment. Am J Trop Med Hyg (2010) 0.88
Vector and reservoir control for preventing leishmaniasis. Cochrane Database Syst Rev (2015) 0.85
Photodynamic therapy induces an immune response against a bacterial pathogen. Expert Rev Clin Immunol (2012) 0.82
A case of imported Leishmania infantum cutaneous leishmaniasis; an unusual presentation occurring 19 years after travel. BMC Infect Dis (2014) 0.79
Exploratory, Phase II Controlled Trial of Shiunko Ointment Local Application Twice a Day for 4 Weeks in Ethiopian Patients with Localized Cutaneous Leishmaniasis. Evid Based Complement Alternat Med (2016) 0.79
A Comparison between the Effects of Glucantime, Topical Trichloroacetic Acid 50% plus Glucantime, and Fractional Carbon Dioxide Laser plus Glucantime on Cutaneous Leishmaniasis Lesions. Dermatol Res Pract (2016) 0.78
Cutaneous leishmaniasis after travel to Cyprus and successful treatment with miltefosine. Am J Trop Med Hyg (2011) 0.78
Rapid healing of cutaneous leishmaniasis by high-frequency electrocauterization and hydrogel wound care with or without DAC N-055: a randomized controlled phase IIa trial in Kabul. PLoS Negl Trop Dis (2014) 0.78
Genetic polymorphisms and drug susceptibility in four isolates of Leishmania tropica obtained from Canadian soldiers returning from Afghanistan. PLoS Negl Trop Dis (2012) 0.77
Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic Review. PLoS Negl Trop Dis (2016) 0.77
Dressings combined with injection of meglumine antimoniate in the treatment of cutaneous leishmaniasis: a randomized controlled clinical trial. PLoS One (2013) 0.76
Update in the treatment of cutaneous leishmaniasis. J Family Community Med (2009) 0.76
Triphenylmethane derivatives have high in vitro and in vivo activity against the main causative agents of cutaneous leishmaniasis. PLoS One (2013) 0.76
Previous exposure to a low infectious dose of Leishmania major exacerbates infection with Leishmania infantum in the susceptible BALB/c mouse. Parasitol Res (2012) 0.76
Antileishmanial Activity of Disulfiram and Thiuram Disulfide Analogs in an Ex Vivo Model System Is Selectively Enhanced by the Addition of Divalent Metal Ions. Antimicrob Agents Chemother (2015) 0.75
Systematic review of biomarkers to monitor therapeutic response in leishmaniasis. Antimicrob Agents Chemother (2014) 0.75
Therapeutic effect of acupuncture in BALB/c model of cutaneous leishmaniasis. Adv Biomed Res (2015) 0.75
The Cochrane Skin Group: a vanguard for developing and promoting evidence-based dermatology. J Evid Based Med (2013) 0.75
Real-time PCR using FRET technology for Old World cutaneous leishmaniasis species differentiation. Parasit Vectors (2016) 0.75
A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan. BMC Infect Dis (2014) 0.75
Leishmania infection: painful or painless? Parasitol Res (2016) 0.75
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol (2007) 7.36
Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis (2008) 3.27
Visceral leishmaniasis: elimination with existing interventions. Lancet Infect Dis (2011) 2.19
Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis (2006) 2.17
Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol (2002) 2.07
Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 2.02
Combination therapy for visceral leishmaniasis. Lancet Infect Dis (2010) 1.96
Of cattle, sand flies and men: a systematic review of risk factor analyses for South Asian visceral leishmaniasis and implications for elimination. PLoS Negl Trop Dis (2010) 1.90
Leishmania/HIV co-infections in the second decade. Indian J Med Res (2006) 1.73
Reporting of methodologic information on trial registries for quality assessment: a study of trial records retrieved from the WHO search portal. PLoS One (2010) 1.66
Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased? Chest (2006) 1.58
Interventions for vitiligo. Cochrane Database Syst Rev (2015) 1.57
Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane Database Syst Rev (2009) 1.45
Wood-smoke exposure (WSE) as a predictor of response and survival in erlotinib-treated non-small cell lung cancer (NSCLC) patients. J Thorac Oncol (2009) 1.39
Interventions for vitiligo. Cochrane Database Syst Rev (2010) 1.35
Natural history of a visceral leishmaniasis outbreak in highland Ethiopia. Am J Trop Med Hyg (2009) 1.29
Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis. J Clin Microbiol (2006) 1.26
Risk factors for visceral leishmaniasis in a new epidemic site in Amhara Region, Ethiopia. Am J Trop Med Hyg (2009) 1.25
Developments in the treatment of visceral leishmaniasis. Expert Opin Emerg Drugs (2009) 1.23
Population movement: a key factor in the epidemiology of neglected tropical diseases. Trop Med Int Health (2010) 1.16
Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study. J Antimicrob Chemother (2003) 1.15
Risk factors for visceral Leishmaniasis among residents and migrants in Kafta-Humera, Ethiopia. PLoS Negl Trop Dis (2013) 1.07
Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients. J Antimicrob Chemother (2004) 1.06
A model of chronic inflammation and pulmonary emphysema after multiple ozone exposures in mice. Am J Physiol Lung Cell Mol Physiol (2011) 1.06
Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis. PLoS Negl Trop Dis (2013) 1.03
Designing and reporting clinical trials on treatments for cutaneous leishmaniasis. Clin Infect Dis (2010) 1.02
Relapses versus reinfections in patients coinfected with Leishmania infantum and human immunodeficiency virus type 1. J Infect Dis (2002) 1.01
Evaluation of two rK39 dipstick tests, direct agglutination test, and indirect fluorescent antibody test for diagnosis of visceral leishmaniasis in a new epidemic site in highland Ethiopia. Am J Trop Med Hyg (2011) 1.00
Narrow-band imaging does not improve detection of colorectal polyps when compared to conventional colonoscopy: a randomized controlled trial and meta-analysis of published studies. BMC Gastroenterol (2011) 0.99
Cochrane systematic reviews are useful to map research gaps for decreasing maternal mortality. J Clin Epidemiol (2013) 0.93
Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar. J Allergy Clin Immunol (2012) 0.93
[Drug advertising and promotion: regulations and extent of compliance in five Latin American countries]. Rev Panam Salud Publica (2011) 0.92
Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis. Vet Immunol Immunopathol (2005) 0.92
Guidelines for designing and reporting clinical trials in vitiligo. Arch Dermatol (2011) 0.89
Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis. Vaccine (2008) 0.89
Endemic transmission of visceral leishmaniasis in Bhutan. Am J Trop Med Hyg (2012) 0.88
Virulence and disease in leishmaniasis: what is relevant for the patient? Trends Parasitol (2004) 0.86
Evidence for a wide occurrence of proton-translocating pyrophosphatase genes in parasitic and free-living protozoa. Biochem Biophys Res Commun (2002) 0.86
Epidemiology of leishmaniasis in Spain based on hospitalization records (1997-2008). Am J Trop Med Hyg (2011) 0.86
Vector and reservoir control for preventing leishmaniasis. Cochrane Database Syst Rev (2015) 0.85
Multilocus microsatellite typing revealed high genetic variability of Leishmania donovani strains isolated during and after a Kala-azar epidemic in Libo Kemkem district, northwest Ethiopia. Microbes Infect (2011) 0.85
HRWeb Americas: a tool to facilitate better research governance in Latin America and the Caribbean. Cad Saude Publica (2012) 0.84
Effects of HIV aspartyl-proteinase inhibitors on Leishmania sp. Exp Parasitol (2010) 0.83
[Antiparasite therapy]. Enferm Infecc Microbiol Clin (2003) 0.82
Drugs for treating giardiasis. Cochrane Database Syst Rev (2012) 0.82
Different strains of mice present distinct lung tissue mechanics and extracellular matrix composition in a model of chronic allergic asthma. Respir Physiol Neurobiol (2008) 0.81
Response from Savioli and colleagues from the Department of Neglected Tropical Diseases, World Health Organization. PLoS Med (2006) 0.81
Prospective registration and results disclosure of clinical trials in the Americas: a roadmap toward transparency. Rev Panam Salud Publica (2011) 0.81
Growth factors for treating diabetic foot ulcers. Cochrane Database Syst Rev (2015) 0.81
The leishmaniasis e-compendium: a geo-referenced bibliographic tool. Trends Parasitol (2010) 0.81
Distribution and trends of hematology and oncology research in Latin America: A decade of uncertainty. Cancer (2013) 0.81
Laparoscopy for the management of acute lower abdominal pain in women of childbearing age. Cochrane Database Syst Rev (2011) 0.81
Clinical trial regulation in Argentina: overview and analysis of regulatory framework, use of existing tools, and researchers' perspectives to identify potential barriers. Rev Panam Salud Publica (2011) 0.80
Antibiotic regimens for management of intra-amniotic infection. Cochrane Database Syst Rev (2014) 0.79
The development of the MeDALL Core Questionnaires for a harmonized follow-up assessment of eleven European birth cohorts on asthma and allergies. Int Arch Allergy Immunol (2014) 0.79
Integrated Allergy and Asthma Prevention and Care: Report of the MeDALL/AIRWAYS ICPs Meeting at the Ministry of Health and Care Services, Oslo, Norway. Int Arch Allergy Immunol (2015) 0.78
CONSORT 2010. Lancet (2010) 0.78
[The concept of equity when developing clinical practice guidelines]. Rev Salud Publica (Bogota) (2011) 0.77
[Clinical and microbiological characteristics of neutropenic enterocolitis in adults with blood cancer in the National Cancer Institute of Bogota D.C. (Colombia)]. Enferm Infecc Microbiol Clin (2004) 0.77
Ambroxol for women at risk of preterm birth for preventing neonatal respiratory distress syndrome. Cochrane Database Syst Rev (2014) 0.76
Isolation and characterization of Leishmania infantum cDNA encoding a protein homologous to eukaryotic elongation factor 1 gamma. Trans R Soc Trop Med Hyg (2002) 0.76
Laparoscopy for the management of acute lower abdominal pain in women of childbearing age. Cochrane Database Syst Rev (2014) 0.76
If it doesn't work, stop it: medicine is a science of prediction and intervention. BMJ (2004) 0.75
[New alliance between the Panamerican Health Organization and the EQUATOR Network to improve writing and publication of articles on health outcomes research]. Med Clin (Barc) (2010) 0.75
Clinical trial registration. N Engl J Med (2005) 0.75
Comment on: Vitiligo Treatment in Childhood: a State of the Art Review. By Tamesis MEB, Morelli JG: Pediatric Dermatology 2010;27(5):437-455. Pediatr Dermatol (2011) 0.75
How should we rate research? Cost of research should be disclosed publicly. BMJ (2006) 0.75
Should we consider Embase in Latin America? J Clin Epidemiol (2004) 0.75
Interventions for central giant cell granuloma (CGCG) of the jaws. Cochrane Database Syst Rev (2009) 0.75
[Restriction of antibiotic sales in pharmacies in Bogotá, Colombia: a descriptive study]. Rev Panam Salud Publica (2011) 0.75
Correction: Risk of bias and confounding of observational studies of Zika virus infection: A scoping review of research protocols. PLoS One (2017) 0.75
[Availability of indicators for monitoring the achievement of "Universal Health" in Latin America and the Caribbean]. Rev Panam Salud Publica (2016) 0.75
Environmental Factors as Key Determinants for Visceral Leishmaniasis in Solid Organ Transplant Recipients, Madrid, Spain. Emerg Infect Dis (2017) 0.75
Colchicine mouth washings to improve oral mucositis in patients with hematological malignancies: a clinical trial. Palliat Support Care (2008) 0.75
Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst Rev (2017) 0.75